|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis显示文摘 | Nathan Mollberg Nuh N. Rahbari Moritz Koch Werner Hartwig Yumiko Hoeger Markus W. Büchler Jürgen Weitz | 2011 | Annals of Surgery2011，，6： | 5 |
| 2 | Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial显示文摘 | Gunnar Folprecht Thomas Gruenberger Wolf O Bechstein Hans-Rudolf Raab Florian Lordick J?rg T Hartmann Hauke Lang Andrea Frilling Jan Stoehlmacher Jürgen Weitz Ralf Konopke Christian Stroszczynski Torsten Liersch Detlev Ockert Thomas Herrmann Eray Goekkurt | 2010 | Lancet Oncology2010，，1： | 3 |
| 3 | Hepatocellular Carcinoma: Current Management and Perspectives for the Future显示文摘 | Nuh N. Rahbari Arianeb Mehrabi Nathan M. Mollberg Sascha A. Müller Moritz Koch Markus W. Büchler Jürgen Weitz | 2011 | Annals of Surgery2011，，3： | 3 |
| 4 | Prognostic relevance of minimal residual disease in colorectal cancer显示文摘Presence of occult minimal residual disease in patients with colorectal cancer(CRC)has a strong prognostic impact on survival.Minimal residual disease plays a major role in disease relapse and formation of metastases in CRC.Analysis of circulating tumor cells(CTC)in the blood is increasingly used in clinical practice for disease monitoring of CRC patients.In this review article the role of CTC,disseminated tumor cells(DTC)in the bone marrow and micrometastases and isolated tumor cells(ITC)in the lymph nodes will be discussed,including literature published until September 2013.Occult disease is a strong prognostic marker for patient survival in CRC and defined by the presence of CTC in the blood,DTC in the bone marrow and/or micrometastases and ITC in the lymph nodes.Minimal residual disease could be used in the future to identify patient groups at risk,who might benefit from individualized treatment options. | Ulrich Bork Robert Grützmann Nuh N Rahbari Sebastian Schlch Marius Distler Christoph Reissfelder Moritz Koch Jürgen Weitz | 2014 | World Journal of Gastroenterology2014，20，30： | 2 |
| 5 | Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma显示文摘 | Shailesh V. Shrikhande MD J?rg Kleeff MD Carolin Reiser MD Jürgen Weitz MD Ulf Hinz MSc Irene Esposito MD Jan Schmidt MD Helmut Friess MD Markus W. Büchler MD | 2007 | Annals of Surgical Oncology2007，，1： | 2 |
| 6 | Distinct Types of Tumor-Initiating Cells Form Human Colon Cancer Tumors and Metastases显示文摘 | Sebastian M. Dieter Claudia R. Ball Christopher M. Hoffmann Ali Nowrouzi Friederike Herbst Oksana Zavidij Ulrich Abel Anne Arens Wilko Weichert Karsten Brand Moritz Koch Jürgen Weitz Manfred Schmidt Christof von Kalle Hanno Glimm | 2011 | Cell Stem Cell2011，，4： | 2 |
| 7 | Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma显示文摘 | Bonertz Andreas Weitz Jürgen Pietsch Dong-Ho Kim Rahbari Nuh N Schlude Christoph Ge Yingzi Juenger Simone Vlodavsky Israel Khazaie Khashayarsha Jaeger Dirk Reissfelder Christoph Antolovic Dalibor Aigner Maximilian Koch Moritz Beckhove Phili | 2009 | Journal of Clinical Investigation2009，，11： | 2 |
| 8 | Colorectal cancer显示文摘 | WEITZ J KOCH M DEBUS J | 2005 | Lancet2005，365，9454： | 1 |
| 9 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom J W Hirsh J Weitz J I | 2002 | Circulation2002，105，14： | 1 |
| 10 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke or,cardiov ascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 11 | Colorectal cancer显示文摘 | Weitz J Koch M Debus J | 2005 | Lancet2005，365，9454： | 1 |
| 12 | Fabry Perot resonances in one-dimensional plasmonic nano- structures 显示文摘 | DORFMULLER J VOGELGESANG R WEITZ R T | 2009 | Nano Lett2009，9，6： | 1 |
| 13 | Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events显示文摘 | Eikelboom JW Hirsh J Weitz JI | 2002 | Circulation2002，105，14： | 1 |
| 14 | Colorectal cancer显示文摘 | Weitz J Koch M Debus J | 2005 | Lancet2005，365，9454： | 1 |
| 15 | 查看详情显示文摘 | Humphry K J Kulkarni P M Weitz D A Morris J F Stone H A | | 0，，： | 1 |
| 16 | Adv Mater显示文摘 | Shah R K Kim J W Weitz D A | 2009 | 21:1 9492009，21，： | 1 |
| 17 | Antithrombotic therapy in patients undergoing percutaneous coronary intervention 显示文摘 | Popma JJ Ohman EM Weitz J | 2001 | Chest2001，119，1： | 1 |
| 18 | New antithromboticdrugs:American College of Chest Physicians evidence-basedclinical practice guidelines(8th edition)显示文摘 | WEITZ JI HIRSH J SAMAMA MM | 2008 | Chest2008，133，6： | 1 |
| 19 | New antithrombotic drugs : American College of Chest Physicians evidence-based clin- ical practice guidelines (8th edition) 显示文摘 | Weitz JI Hirsh J Samama MM | 2008 | Chest2008，133，6： | 1 |
| 20 | Association of splenecto- my with postoperative complications in patients with proximal gas- tric and gastroesophageal junction cancer 显示文摘 | Weitz J Jaques DP Brennan M | 2004 | Ann Surg Oncol2004，11，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员